ask="0.90"
ask_size="100"
average_daily_volume="115902"
bid="0.83"
bid_size="100"
book_value="0.69"
change="-0.05"
change_from_200_day_moving_average="-0.52"
change_from_50_day_moving_average="-0.31"
change_from_52_week_high="-7.09"
change_From_52_week_low="0.05"
change_in_percent="-5.49%"
close="0.86"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.16"
ebitda="-17.60M"
eps_estimate_current_year="-0.82"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.73"
ex_dividend_date="N/A"
float_shares="6119000"
high="0.91"
high_52_weeks="7.95"
last_trade_date="3/14/2017"
last_trade_price="0.86"
last_trade_size="200"
last_trade_time="3:58pm"
low="0.83"
low_52_weeks="0.81"
market_capitalization="14.10M"
moving_average_200_day="1.38"
moving_average_50_day="1.17"
name="Bioblast Pharma Ltd."
notes="N/A"
one_year_target_price="9.00"
open="0.91"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-37.64%"
percent_change_from_50_day_moving_average="-26.44%"
percent_change_from_52_week_high="-89.18%"
percent_change_from_52_week_low="+6.17%"
previous_close="0.91"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.31"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.23"
stock_exchange="NGM"
symbol="ORPN"
volume="72004"
weeks_range_52="0.81 - 7.95"
